Report ID : 10352362 |
Published Date : 21 Mar 2025 |
Report Format : PDF,PPT |
Delivery Timeline :48-72 Business Hours
Global Organs-on-Chips Market Highlights Over 2020 - 2030
The global organs-on-chips market is estimated to garner a revenue of USD 772.72 Million by the end of 2030, by growing at a CAGR of 36.54% over the forecast period, i.e., 2021 – 2030. Moreover, the market generated a revenue of USD 31.37 Million in the year 2020. The growth of the market can be attributed to growing prevalence of different types of chronic diseases worldwide, such as cancer, dementia, and diabetes among others, and therefore the rising need for advanced pharmaceutical drugs to treat these diseases. According to the statistics by the World Health Organization (WHO), globally, around 55 Million people were known to have dementia. Moreover, with the surge in geriatric population globally, the number of people having dementia is expected to reach 78 Million by 2030 and further to 139 Million by 2050. Organs-on-chips, also known as organs-on-a-chip (OOC), are used to emulate a wide range of organ-level functions, which otherwise are not feasible using the conventional 2D and 3D culture systems. These are widely used to develop advanced pharmaceutical drugs and are also in demand amongst healthcare researchers for a wide range of human diseases, including COVID-19, influenza, radiation exposure, cystic fibrosis, and others. Some of the most recent researches that are under process using organs-on-chips are for Alzheimer’s disease, microbiome health, and in the study of individualized toxicity responses.
CLICK TO DOWNLOAD A SAMPLE REPORT
The growth of the market can also be attributed to the increasing advancements in organs-on-chips technology, backed by the rising preference for these technology by a number of research laboratories. The technology helps in the detection of species-specific toxicities, therefore allowing more accurate predictions of the effects of drugs on humans. Additionally, the increasing research and development expenditure and the rise in focus on drug discoveries, are some of the key market opportunities expected to boost the market growth in the coming years.
Global Organs-on-Chips Market Regional Synopsis
Regionally, the global organs-on-chips market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in North America is anticipated to garner the largest revenue of USD 372.61 Million by the end of 2030, up from a revenue of USD 18.09 Million in the year 2020. The growth of the market in the region can primarily be attributed to the presence of increasing number of medical research organizations who are working on the development of customized microcellular environments, so as to capture the structural complexity of organs. Countries, such as the United States, has introduced a ban on animal testing in the year 2007, post which, pharmaceutical, chemical and cosmetic industries are increasingly opting for OOCs that can help them test the toxicity of drugs, chemicals and varied cosmetic products. In addition to this, the increasing expenditure on medical R&D in the region is also projected to expand the market growth in the coming years. In the other statistics by the WHO, as of December 2021, the health gross domestic expenditure on R&D (GERD) in the Americas, registered 0.03% as a share of GDP, whereas, in terms of health GERD as a share of GERD, the region registered 12.5% in the same period.
The market in Europe, on the other hand, is anticipated to garner the second-largest revenue of USD 185.30 Million by the end of 2030, up from a revenue of USD 6.65 Million in the year 2020. The market in the region is further segmented by country into Germany, United Kingdom, Italy, France, Spain, Russia, Netherland, and the Rest of Europe. The market in the United Kingdom is projected to display the largest revenue of USD 41.54 Million by the end of 2030, up from a revenue of USD 1.50 Million in the year 2020.
Growth Drivers and Challenges Impacting the Growth of the Global Organs-on-Chips Market
Growth Drivers
-
Growing Use of Organ-on-Chips in Medical Research
-
Increasing Need for the Development of Advanced Pharmaceutical Drugs
Challenges
-
High Cost of OOC Devices
-
Nascent Stage of the Technology
Global Organs-on-Chips Market Segmentation Synopsis
The global organs-on-chips market is segmented by organ type into lung, intestine, kidney, brain, liver, and others. Out of these, the lung segment is anticipated to garner the largest revenue of USD 178.79 Million by the end of 2030, up from a revenue of USD 7.71 Million in the year 2020. By offering, the market is segmented into product, and services. Out of these, the services segment is anticipated to garner the largest revenue by the end of 2030, and also grow with a CAGR of 35.41% during the forecast period. By application, the market is segmented into drug discovery, toxicology research, disease modeling, and others. Out of these, the toxicology research segment is anticipated to garner the largest revenue of USD 244.66 Million by the end of 2030, up from a revenue of USD 9.91 Million in the year 2020. By end-user, the market is segmented into pharmaceutical & biopharmaceutical companies, academic & research institutes, and others. Out of these, the pharmaceutical & biopharmaceutical companies segment is projected to garner the largest revenue of USD 435.87 Million by the end of 2030, up from a revenue of USD 17.39 Million in the year 2020.
Key Companies Dominating the Market
Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the global organs-on-chips market that are included in our report are Emulate, Inc., CN Bio Innovations Limited, TissUse GmbH, InSphero AG, Elvesys, MesoBioTech, AxoSim, CHERRY BIOTECH, Nortis, Inc., BiomimX S.r.l., MIMETAS B.V., KYODO INTERNATIONAL INC., AGC Inc., and others.
Latest Developments in the Global Organs-on-Chips Market:
-
December 21st, 2021: Emulate, Inc. announced that it has sent its Brain-Chip to study the effects of microgravity on human brain physiology to the International Space Station U.S. National Laboratory (ISS National Lab).
-
February 28th, 2019: CN Bio Innovations Limited announced that it has received an exclusive license to bring 10 organs together on a chip. The exclusive license to technology has been provided by the Massachusetts Institute of Technology (MIT).
Key Reasons to Buy Our Report
-
The report covers detailed analysis comprising market share attained by each market segment and its sub-segments.
-
It covers market dynamics including growth drivers, trends, potential opportunities, price trend analysis and challenges that impact the market growth.
-
The report includes detailed company profiles of the major players dominating the market.
-
We use effective research methodologies to calculate the market numbers and provide value-added assessment for overall growth.
-
We provide customized reports as per the clients’ requirement helping them to see possible and unexpected challenges and unforeseen opportunities in order to help them reach their goal.
1. Market Definition and Segmentation
1.1. Definition
1.2.Market Segmentation
2. Assumptions and Acronyms
3. Research Methodology
3.1. Research Process
3.2. Primary Research
3.3. Secondary Research
4. Executive Summary – Global Organs-on-Chips Market
5. Analysis of Market Dynamics
5.1. Market Drivers
5.2. Market Trends
6. Key Market Opportunities
7. Major Roadblocks for the Market Growth
8. Industry Value Chain Analysis
9. Regulatory & Standard Landscape
10. Industry Risk Analysis
11. Publication Analysis
12. Average Pricing Analysis
13. COVID-19 Impact on the Global Organs-on-Chips Market
14.Analysis on Ongoing Trends
15. Investment Analysis
16.Analysis on Ongoing Clinical Studies on Potential Treatments
17. Technical Considerations and Challenges
18. Analysis on Commercial Considerations and Hurdles
19.Competitive Positioning
20. Competitive Structure
20.1. Company Market Share Analysis
20.2. Competitive Benchmarking
20.3. Company Profiles
20.3.1. Emulate, Inc.
20.3.2. CN Bio Innovations Limited
20.3.3. TissUse GmbH
20.3.4. InSphero AG
20.3.5. Elvesys
20.3.6. MesoBioTech
20.3.7. AxoSim
20.3.8. CHERRY BIOTECH
20.3.9. Nortis, Inc.
20.3.10. BiomimX S.r.l.
20.3.11. MIMETAS B.V.
20.3.12. KYODO INTERNATIONAL INC.
20.3.13. AGC Inc.
21. Global Organs-on-Chips Market 2020-2030
21.1. Market Overview
21.2. By Value (USD Million)
21.3. Market Segmentation:
21.3.1. By Organ Type
21.3.1.1. Lung, 2020-2030F (USD Million)
21.3.1.2. Intestine, 2020-2030F (USD Million)
21.3.1.3. Kidney, 2020-2030F (USD Million)
21.3.1.4. Brain, 2020-2030F (USD Million)
21.3.1.5. Liver, 2020-2030F (USD Million)
21.3.1.6. Others, 2020-2030F (USD Million)
21.3.2. By Offering
21.3.2.1. Product, 2020-2030F (USD Million)
21.3.2.2. Services, 2020-2030F (USD Million)
21.3.3. By Application
21.3.3.1. Drug Discovery, 2020-2030F (USD Million)
21.3.3.2. Toxicology Research, 2020-2030F (USD Million)
21.3.3.3. Disease Modeling, 2020-2030F (USD Million)
21.3.3.4. Others, 2020-2030F (USD Million)
21.3.4. By End-User
21.3.4.1. Pharmaceutical & Biopharmaceutical Companies, 2020-2030F (USD Million)
21.3.4.2. Academic and Research Institutes, 2020-2030F (USD Million)
21.3.4.3. Others, 2020-2030F (USD Million)
21.3.5. By Region
21.3.5.1. North America, 2020-2030F (USD Million)
21.3.5.2. Europe, 2020-2030F (USD Million)
21.3.5.3. Asia Pacific, 2020-2030F (USD Million)
21.3.5.4. Latin America, 2020-2030F (USD Million)
21.3.5.5. Middle East & Africa, 2020-2030F (USD Million)
22. North America Organs-on-Chips Market 2020-2030
22.1. Market Overview
22.2. By Value (USD Million)
22.3. Market Segmentation:
22.3.1. By Organ Type
22.3.1.1. Lung, 2020-2030F (USD Million)
22.3.1.2. Intestine, 2020-2030F (USD Million)
22.3.1.3. Kidney, 2020-2030F (USD Million)
22.3.1.4. Brain, 2020-2030F (USD Million)
22.3.1.5. Liver, 2020-2030F (USD Million)
22.3.1.6. Others, 2020-2030F (USD Million)
22.3.2. By Offering
22.3.2.1. Product, 2020-2030F (USD Million)
22.3.2.2. Services, 2020-2030F (USD Million)
22.3.3. By Application
22.3.3.1. Drug Discovery, 2020-2030F (USD Million)
22.3.3.2. Toxicology Research, 2020-2030F (USD Million)
22.3.3.3. Disease Modeling, 2020-2030F (USD Million)
22.3.3.4. Others, 2020-2030F (USD Million)
22.3.4. By End-User
22.3.4.1. Pharmaceutical & Biopharmaceutical Companies, 2020-2030F (USD Million)
22.3.4.2. Academic and Research Institutes, 2020-2030F (USD Million)
22.3.4.3. Others, 2020-2030F (USD Million)
22.3.5. By Country
22.3.5.1. United States, 2020-2030F (USD Million)
22.3.5.2.Canada, 2020-2030F (USD Million)
23. Europe Organs-on-Chips Market 2020-2030
23.1. Market Overview
23.2. By Value (USD Million)
23.3. Market Segmentation:
23.3.1. By Organ Type
23.3.2. By Offering
23.3.3. By Application
23.3.4. By End-User
23.3.5. By Country
23.3.5.1. Germany, 2020-2030F (USD Million)
23.3.5.2.United Kingdom, 2020-2030F (USD Million)
23.3.5.3.France, 2020-2030F (USD Million)
23.3.5.4.Italy, 2020-2030F (USD Million)
23.3.5.5. Spain, 2020-2030F (USD Million)
23.3.5.6.Russia, 2020-2030F (USD Million)
23.3.5.7. Netherland, 2020-2030F (USD Million)
23.3.5.8. Rest of Europe, 2020-2030F (USD Million)
24. Asia Pacific Organs-on-Chips Market 2020-2030
24.1. Market Overview
24.2. By Value (USD Million)
24.3. Market Segmentation:
24.3.1. By Organ Type
24.3.2. By Offering
24.3.3. By Application
24.3.4. By End-User
24.3.5. By Country
24.3.5.1. China, 2020-2030F (USD Million)
24.3.5.2.India, 2020-2030F (USD Million)
24.3.5.3.Japan, 2020-2030F (USD Million)
24.3.5.4.South Korea, 2020-2030F (USD Million)
24.3.5.5. Australia, 2020-2030F (USD Million)
24.3.5.6.Singapore, 2020-2030F (USD Million)
24.3.5.7. Rest of Asia Pacific, 2020-2030F (USD Million)
25. Latin America Organs-on-Chips Market 2020-2030
25.1. Market Overview
25.2. By Value (USD Million)
25.3. Market Segmentation:
25.3.1. By Organ Type
25.3.2. By Offering
25.3.3. By Application
25.3.4. By End-User
25.3.5. By Country
25.3.5.1. Brazil, 2020-2030F (USD Million)
25.3.5.2. Argentina, 2020-2030F (USD Million)
25.3.5.3. Mexico, 2020-2030F (USD Million)
25.3.5.4. Rest of Latin America, 2020-2030F (USD Million)
26. Middle East & Africa Organs-on-Chips Market 2020-2030
26.1. Market Overview
26.2. By Value (USD Million)
26.3. Market Segmentation:
26.3.1. By Organ Type
26.3.2. By Offering
26.3.3. By Application
26.3.4. By End-User
26.3.5. By Country
26.3.5.1. GCC, 2020-2030F (USD Million)
26.3.5.2.Israel, 2020-2030F (USD Million)
26.3.5.3.South Africa, 2020-2030F (USD Million)
26.3.5.4.Rest of Middle East & Africa, 2020-2030F (USD Million)
